|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Changing strategies in diagnosis and management of hilar cholangiocarcinoma 显示文摘 | Figueras J Llado L Vails C | 2000 | Liver Transpl2000，6，6： | 1 |
| 2 | Complete versus selective portal triad clamping for minor liver resections:a prospective randomized显示文摘 | Fiqueras J Llado L Ruiz D | 2005 | Ann Surg2005，241，： | 1 |
| 3 | Complete versus selective portal triad clamping for minor liver resections:a prospective randomized trial显示文摘 | Figueras J Llado L Ruiz D | | 0，，04： | 1 |
| 4 | Complete Versus Selective Portal Triad Clamping for Minor Liver Resections,A Prospective Randomized Trial显示文摘 | Figueras J Llado L Ruiz D | 2005 | Ann Surg2005，241，： | 1 |
| 5 | A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization显示文摘 | Virgili J Figueras J | 2000 | Cancer2000，88，1： | 1 |
| 6 | Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial显示文摘 | Figueras J Llado L Ruiz D | 2005 | Ann Surg2005，241，4： | 1 |
| 7 | Is MELD really the definitive score for liver allocation? 显示文摘 | LLADO L FIGUERAS J MEMBA R | 2002 | Liver Transpl2002，8，9： | 1 |
| 8 | Immunosuppression without steroids in liver transplantation is safe and reduc- es infection and metabolic complications: results from a prospective multicenter randomized study显示文摘 | Llado L Xiol X Figueras J | 2006 | J Hepatol2006，44，4： | 1 |
| 9 | Diagnostic and therapeutic management of hepatic artery thrombosis after liver transplantation显示文摘 | Torras J Llado L Figueras J | 1999 | Transplant Proc1999，31，6： | 1 |
| 10 | Open-label,phaseⅡ,multicenter,randomized study of the efficacy and safety of twodose levels of pertuzumab,a human epidermal growth factor re-ceptor 2dimerization inhibitor,in patients with human epider-mal growth factor receptor 2-negative metastatic breast cancer显示文摘 | Gianni L Llado A Bianchi G | 2010 | J Clin Oncol2010，28，7： | 1 |
| 11 | Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial 显示文摘 | Figueras J Llado L Ruiz D | 2005 | Ann Surg2005，241，4： | 1 |
| 12 | Influence of endothelin1 on hemodynamics during liver transplantation with and without temporary portocaval shunt:results of a clinical randomized study显示文摘 | Llado L Ramos E Figueras J | 2002 | Liver Transpl2002，8，1： | 1 |
| 13 | Temporary portoeaval shunt during liver transplantation with vena cava preservation: results of a prospective randomized study显示文摘 | Figueras J Llado L Ramos E | 2001 | Liver Transpl2001，7，10： | 1 |
| 14 | Application of fibrin glue sealant after hepatectomy does not seem justified-results of a randomized study in 300 patients显示文摘 | Figueras J Llado L Miro M | 2007 | Ann Surg2007，245，4： | 1 |
| 15 | Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial 显示文摘 | Figueras J Llado L Ruiz D | 2005 | Ann Surg2005，241，4： | 1 |
| 16 | 查看详情显示文摘 | Teo S L Lin V K Marry R Large N Llado E A Arbouet A Gi-rard C Aizpurua J Tripathy S Mlayah A | | 0，，： | 1 |
| 17 | Hilar dissection versusthe “Gissonean” approach and stapling of the pedicle for majorhepatectomies: a prospective, randomized trial 显示文摘 | Figueras J Lopez-Ben S Llado L | 2003 | Ann Surg2003，238，1： | 1 |
| 18 | Open-label, phase II , multieenter, randomized study of the efficacy and safety of two dose levels of pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer显示文摘 | Gianni L Llado A Bianchi G | 2010 | J Clin Oncol2010，28，7： | 1 |
| 19 | Changing strategies in diagnosis and management of hilar cholangiocarcinoma显示文摘 | Figueras J Llado L Valls C | 2000 | Liver Transpl2000，6，6： | 1 |
| 20 | Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial显示文摘 | Figueras J Llado L Ruiz D | 2005 | Ann Surg2005，241，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员